Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center
|
November 5, 2024
Isolated Limb Infusion as First, Second, or Third or Later-Line Therapy for Metastatic In-Transit Melanoma
Aleena Boby, Michelle M Dugan, Helana Ghali, et al.
The American Journal of Dermatopathology
|
September 3, 2025
PRAME Expression in Recurrent/Persistent Melanocytic Nevi
Alison H Kucharik, Helana Ghali, Doniya Milani, et al.
Archives of Dermatological Research
|
October 30, 2024
Examining dermatology residency applicant profiles for the 2023-2024 cycle: a cross-sectional analysis
Helana Ghali, Logan R Smith, Kayla Rubalsky, et al.
Journal of Drugs in Dermatology : JDD
|
May 6, 2025
Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma
Shaliz Aflatooni, Gabriela Pinero-Crespo, Sunny Kahlon, et al.
Dermatology Online Journal
|
June 5, 2026
A comprehensive approach to skin protection against ultraviolet radiation: Integrating sunscreens, antioxidants, DNA repair agents, oral supplements, and probiotics
Mina Ghali, Bishoy Abdelmalik, Logan Rs Hubbert, et al.
Dermatology Online Journal
|
June 17, 2025
Topical cantharidin use in dermatology: an updated review
Helana Ghali, Logan R Smith, Amanda Krenitsky, et al.
Microbes and Infection
|
February 5, 2020
A potential tradeoff between feeding rate and aversive learning determines intoxication in a Caenorhabditis elegans host-pathogen system
Pallavi Velagapudi, Rachel Ghoubrial, Ratnavi Shah, et al.
Annals of Surgical Oncology
|
October 24, 2024
ASO Visual Abstract: Isolated Limb Infusion for Limb Threatening Sarcomas
Shaliz Aflatooni, Michelle M Dugan, Aleena Boby, et al.
Annals of Surgical Oncology
|
August 22, 2024
Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma
Helana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Annals of Surgical Oncology
|
October 8, 2024
ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma
Helana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cancer Control : Journal of the Moffitt Cancer Center
|
November 5, 2024
Isolated Limb Infusion as First, Second, or Third or Later-Line Therapy for Metastatic In-Transit Melanoma
Aleena Boby, Michelle M Dugan, Helana Ghali, et al.
The American Journal of Dermatopathology
|
September 3, 2025
PRAME Expression in Recurrent/Persistent Melanocytic Nevi
Alison H Kucharik, Helana Ghali, Doniya Milani, et al.
Archives of Dermatological Research
|
October 30, 2024
Examining dermatology residency applicant profiles for the 2023-2024 cycle: a cross-sectional analysis
Helana Ghali, Logan R Smith, Kayla Rubalsky, et al.
Journal of Drugs in Dermatology : JDD
|
May 6, 2025
Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma
Shaliz Aflatooni, Gabriela Pinero-Crespo, Sunny Kahlon, et al.
Dermatology Online Journal
|
June 5, 2026
A comprehensive approach to skin protection against ultraviolet radiation: Integrating sunscreens, antioxidants, DNA repair agents, oral supplements, and probiotics
Mina Ghali, Bishoy Abdelmalik, Logan Rs Hubbert, et al.
Dermatology Online Journal
|
June 17, 2025
Topical cantharidin use in dermatology: an updated review
Helana Ghali, Logan R Smith, Amanda Krenitsky, et al.
Microbes and Infection
|
February 5, 2020
A potential tradeoff between feeding rate and aversive learning determines intoxication in a Caenorhabditis elegans host-pathogen system
Pallavi Velagapudi, Rachel Ghoubrial, Ratnavi Shah, et al.
Annals of Surgical Oncology
|
October 24, 2024
ASO Visual Abstract: Isolated Limb Infusion for Limb Threatening Sarcomas
Shaliz Aflatooni, Michelle M Dugan, Aleena Boby, et al.
Annals of Surgical Oncology
|
August 22, 2024
Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma
Helana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Annals of Surgical Oncology
|
October 8, 2024
ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma
Helana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Page
of 3